論文 - 谷川原　祐介

Prospective evaluation of the relationship between response and exposure of total and unbound erlotinib in non-small cell lung cancer patients.

H. Kenmotsu, C.K. Imamura, T. Kawamura, T. Oyakawa, S. Omori, K. Nakashima, K. Wakuda, A. Ono, T. Taira, T. Naito, H. Murakami, N. Yamamoto, T. Takahashi, Y. Tanigawara

Cancer Chemother. Pharmacol 90 （ 2 ） 115 - 123 2022年07月

共著, 最終著者

Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials.

E. Booka, C.K. Imamura, M. Takeuchi, H. Kawakubo, H. Takeuchi, Y. Tanigawara, Y. Kitagawa, N. Boku

Gastric Cancer 25 （ 4 ） 770 - 782 2022年03月

研究論文（学術雑誌）, 共著

Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance data.

Y. Otani, H. Kasai, Y. Tanigawara

CPT Pharmacometrics Syst Pharmacol 11 （ 1 ） 44 - 54 2022年

研究論文（学術雑誌）, 共著, 最終著者, 責任著者

Pharmacodynamic Model-based Safety Management of Eribulin-induced Myelosuppression in Patients with Breast Cancer.

H. Kasai, K.L. Poppenberg, V. Fermanelli, Y. Otani, Y. Tanigawara

Ther. Drug Monit. 2022年

研究論文（学術雑誌）, 共著, 最終著者, 責任著者

Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance data

Otani, Y. Kasai, H. Tanigawara, Y.

CPT Pharmacometrics Syst Pharmacol 2021年10月

共著, 査読有り,  ISSN  2163-8306

• Access to Document (DOI)

Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application

M. Takeuchi, C. K. Imamura, E. Booka, H. Takeuchi, T. Mizukami, T. Kawakami, T. Funakoshi, K. Wakuda, Y. Aoki, Y. Hamamoto, M. Kitago, H. Kawakubo, N. Boku, Y. Tanigawara, Y. Kitagawa

Cancer Science 112 （ 2 ） 751 - 759 2021年02月

研究論文（学術雑誌）, 共著, 査読有り

Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance data

Y. Otani, H. Kasai, Y. Tanigawara

CPT Pharmacometrics Syst Pharmacol 2021年01月

研究論文（学術雑誌）, 共著, 査読有り

Population Pharmacokinetics of Voriconazole in Patients With Invasive Aspergillosis: Serum Albumin Level as a Novel Marker for Clearance and Dosage Optimization

P. Chantharit, M. Tantasawat, H. Kasai, Y. Tanigawara

Therapeutic Drug Monitoring 42 （ 6 ） 872 - 879 2020年12月

研究論文（学術雑誌）, 共著, 査読有り

Prediction of Fracture Risk From Early-Stage Bone Markers in Patients With Osteoporosis Treated With Once-Yearly Administered Zoledronic Acid

H. Kasai, Y. Mori, A. Ose, M. Shiraki, Y. Tanigawara

Journal of Clinical Pharmacology 2020年11月

研究論文（学術雑誌）, 共著, 査読有り

• Access to Document (DOI)

Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer

T. Tsushima, H. Kasai, Y. Tanigawara

Cancer Chemotherapy and Pharmacology 86 （ 4 ） 487 - 495 2020年10月

研究論文（学術雑誌）, 共著, 査読有り

CYP2D6 Genotype-Guided Tamoxifen Dosing, in Hormone Receptor-Positive Metastatic Breast Cancer (TARGET-1): A Randomized, Open-Label, Phase Ⅱ Study

K. Tamura, C.K. Imamura, T. Takano, S. Saji, T. Yamanaka, K, Yonemori, M. Takahashi, J. Tsurutani, R. Nishimura, K. Sato, A. Kitani, N. Ueno, T. Mushiroda, M. Kudo, Y. Fujiwara, Y. Tanigawara

Journal of Clinical Oncology 38 （ 6 ） 558 - 566 2020年02月

研究論文（学術雑誌）, 共著

• Access to Document (DOI)

Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity

T. Kawamura, C.K. Imamura, H. Kenmotsu, T. Taira, S. Omori, K. Nakashima, K. Wakuda, A. Ono, T. Naito, H. Murakami, T. Mushiroda, T. Takahashi, Y. Tanigawara

Cancer Chemotherapy and Pharmacology （Springer）  85 （ 3 ） 605 - 614 2020年02月

共著

Cerebrospinal pharmacokinetic and Pharmacodynamic Analysis of efficacy of meropenem in paediatric patients with bacterial meningitis

Y. Ohata, Y. Tomita, K. Sunakawa, G.L. Drusano, Y. Tanigawara

International Journal of Antimicrobial Agents （Elsevier）  54   292 - 300 2019年07月

研究論文（学術雑誌）, 共著

Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer

Kawata, T. Higashimori, M. Itoh, Y. Tomkinson, H. Johnson, M. G. Tang, W. Nyberg, F. Jiang, H. Tanigawara, Y.

Cancer Chemotherapy and Pharmacology （Springer）  83   849 - 858 2019年02月

共著

Individualized Dosing of Axitinib Based on First-Dose Area Under the Concentration-Time Curve for Metastatic Renal-Cell Carcinoma

Y. Miura, C.K. Imamura, K. Uchino, T. Kishida, N. Matsubara, T. Shinojima, K. Kondo, F. Hongo, K. Yoshimura, Y. Tanigawara, T. Takano

Clinical Genitourinary Cancer 17 （ 1 ） e1 - e11 2019年02月

研究論文（学術雑誌）, 共著, 査読有り

Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype-Guided Dosing of Tamoxifen

T. Nakamura, K. Toshimoto, W. Lee, C. K. Imamura, Y. Tanigawara, Y. Sugiyama

CPT Pharmacometrics Syst Pharmacol 7 （ 7 ） 474 - 482 2018年07月

研究論文（学術雑誌）, 共著, 査読有り

Pharmacodynamic analysis of eribulin safety in breast cancer patients using real-world postmarketing surveillance data

T. Kawamura, H. Kasai, V. Fermanelli, T. Takahashi, Y. Sakata, T. Matsuoka, M. Ishii, Y. Tanigawara

Cancer Science （Wiley）  109   2822 - 2829 2018年06月

共著, 査読有り

Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker

Y. Mori, H. Kasai, A. Ose, M. Serada, M. Ishiguro, M. Shiraki, Y. Tanigawara

Osteoporosis International 29 （ 5 ） 1155 - 1163 2018年02月

• Access to Document (DOI)

Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer

T. Kawamura, H. Kenmotsu, S. Omori, K. Nakashima, K. Wakuda, A. Ono, T. Naito, H. Murakami, K. Omae, K. Mori, Y. Tanigawara, T. Nakajima, Y. Ohde, M. Endo, T. Takahashi,

Clin Lung Cancer 19 （ 2 ） 247 - 252 2017年08月

共著

• Access to Document (DOI)

Population Pharmacokinetics of Diazoxide in Children with Hyperinsulinemic Hypoglycemia

R. Kizu, K. Nishimura, R. Sato, K. Kosaki, T. Tanaka, Y. Tanigawara, T. Hasegawa

Horm. Res. Paediatr. 88 （ 5 ） 316 - 323 2017年07月

• Access to Document (DOI)